KUALA LUMPUR, Nov 17 (Bernama) -- Medical technology company, ONWARD Medical N.V. announced Grégoire Courtine, Ph.D. has demonstrated the effectiveness of ONWARD’s ARC Therapy to stabilise blood pressure after spinal cord injury during his Presidential Special Lecture at NEUROSCIENCE 2021.
Courtine is Professor of Neuroscience at the Swiss Federal Institute of Technology (EPFL) and co-Director of NeuroRestore, according to a statement.
“Paralysis and loss of sensation are the more commonly known impacts of spinal cord injury, but a potentially more serious complication is orthostatic hypotension - low blood pressure tied to changes in body position.
“We were excited to demonstrate and discuss how this new approach may provide a viable and important therapy for people with spinal cord injury,” he said.
This novel therapy is currently being investigated in the STIMO HEMO study, building on a discovery first published in Nature that identifies the low thoracic spinal cord as a hemodynamic ‘hotspot’, which when stimulated via a proprietary algorithm called ARC Therapy, has the potential to restore blood pressure stability after spinal cord injury.
During his Presidential Special Lecture, Courtine showed how stimulation of the hemodynamic hotspot elevated blood pressure in one of the STIMO HEMO participants.
ONWARD Medical N.V. creates innovative therapies to restore movement, independence, and health in people with spinal cord injury.
ONWARD’s work builds on over a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories.
It is headquartered at the High Tech Campus in Eindhoven, the Netherlands and the EPFL Innovation Park in Lausanne, Switzerland, with a growing US presence in Boston, Massachusetts, USA.
-- BERNAMA
No comments:
Post a Comment